Stay updated with breaking news from Lumen Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lumen Bioscience, a clinical-stage biopharma company developing biologic drugs for highly prevalent disease, has received $5.5 million in new funding from the U.S. Department of Defense, to develop technologies for needle-free vaccines.
Lumen Bioscience, a clinical-stage biopharma company developing biologic drugs for highly prevalent disease, has received $5.5 million in new funding from the U.S. Department of Defense, to develop technologies for needle-free vaccines.
Lumen Bioscience has been granted $16.2 million by the U.S. Department of Defense to advance its C. difficile infection (CDI) treatment.
Lumen Bioscience developed an enzyme that targets the methane-producing microorganisms in a cow’s digestive system. Cow burps are a major source of methane, a…
Lumen Bioscience was announced Friday as the winner of the $1.5 million Wilkes Center Climate Prize from the University of Utah to expand its work on reducing methane emissions in the atmosphere \u2014 by reducing cow farts.